Avidity Partners Management LP Has $62.47 Million Stock Position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)

Avidity Partners Management LP lifted its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,500,328 shares of the company’s stock after buying an additional 718,478 shares during the quarter. Fusion Pharmaceuticals […]

Related Keywords

China ,Canada ,United States ,New York ,William Blair ,Quarter For Fusion Pharmaceuticals ,News Ratings For Fusion Pharmaceuticals Daily ,Fusion Pharmaceuticals Stock Performance ,Fusion Pharmaceuticals Inc ,Fusion Pharmaceuticals ,Exchange Commission ,York State Common Retirement Fund ,Tower Research Capital ,China Universal Asset Management Co ,Nasdaq ,Investment Management ,Avidity Partners Management ,Free Report ,Partners Management ,Research Capital ,Universal Asset Management ,Capital Management ,Get Free Report ,Pharmaceuticals Inc ,Visit Holdingschannel ,Fusion Pharmaceuticals Daily ,